HMC-IP attorney Anna Hally reports on the recent update to the Guidelines for Examination at the EPO regarding the patenting of antibodies.
Spring 2021 updates from our China Office
HMC-IP attorney Barry Moore reports on how the EPO applies the Article 84 EPC clarity provisions in practice and drafting lessons to be learnt.
HMC-IP attorney Laurence Bibow provides a brief review of the recent UK Supreme Court Judgment in Unwired Planet and Conversant.
Winter 2020 updates from our China Office
Autumn 2020 updates from our China Office
Life Sciences Newsletter Summer/Autumn 2020
Summer 2020 updates on European Patent and Trade Mark Law And Practice
Spring 2020 updates on European Patent and Trade Mark Law and Practice
Life Sciences Newsletter Winter 2019
An update on European Patent Law and Practice for Summer 2019
Spring 2019 updates on European Patent and Trade Mark Law and Practice
Spring 2019 update on European Patent and Trade Mark Law and Practice
Updates on European Patent Law and Practice in Life Sciences - Spring 2019
Autumn 2018 update on European Patent and Trade Mark Law and Practice
On 25 July 2018 the CJEU issued their long-awaited judgement concerning Gilead's SPC for the anti- HIV Drug TRUVADA®.
Summer 2018 update on European Patent and Trade Mark Law and Practice
Spring 2018 update on European Patent and Trade Mark Law and Practice
December 2018 Life Sciences update
A concise review of SEPs and FRAND licences
A guide to IP for Agricultural technology companies
An introductory guide to IP issues for companies in the food and drinks industry
A concise guide to IP issues for Medical Technology Companies
What Brexit means for Intellectual Property
